Sam Brusco, Associate Editor05.09.22
Philips has earned U.S. Food and Drug Administration (FDA) 510(k) clearance for its new MR 7700 3.0T MR system.
MR 7700’s XP gradients offer high accuracy to support confident diagnosis using the company’s high quality diffusion imaging and advanced neuroscience. It also features a multi-nuclei imaging and spectroscopy solution to explore new clinical pathways. Radiologists can image six different clinically relevant nuclei across all anatomies. This boosts diagnostic confidence and adds important metabolic information to MR exams.
“Our highly specialized team of MR physicists are very happy with the ease of use of Philips’ MR 7700 system, especially the implementation of new imaging protocols which is quite simple,” Prof. Walter Heindel, Professor of Radiology and Chairman of the Department of Radiology at the University Hospital Münster in Germany told the press. “The low effort required for modifying scan parameters and protocols supports fast and easy experimentation with imaging techniques. These latest features clearly help improve our patient and staff experience and distinguish Philips as one of the main reasons we choose this system.”
MR 7700’s ultra-high gradients and artificial intelligence (AI)-driven touchless patient sensing and motion detection can help address patient volume upswing.
“Enhanced with ultra-high gradients and artificial intelligence, Philips MR 7700 is built to deliver on the high-quality clinical performance expectations of today, and to facilitate the most demanding and promising research programs that will help drive the future of MR imaging, without sacrificing workflow efficiency or wide-bore patient comfort,” said Arjen Radder, General Manager of Magnetic Resonance and Diagnostic X-ray at Philips. “Combined with its AI-driven smart connected imaging capabilities, optimized workflows and integrated clinical solutions help meet the quadruple aim of healthcare by improving MR department productivity, enhancing the patient and staff experience, helping to deliver high-quality diagnostic outcomes.”
MR 7700’s XP gradients offer high accuracy to support confident diagnosis using the company’s high quality diffusion imaging and advanced neuroscience. It also features a multi-nuclei imaging and spectroscopy solution to explore new clinical pathways. Radiologists can image six different clinically relevant nuclei across all anatomies. This boosts diagnostic confidence and adds important metabolic information to MR exams.
“Our highly specialized team of MR physicists are very happy with the ease of use of Philips’ MR 7700 system, especially the implementation of new imaging protocols which is quite simple,” Prof. Walter Heindel, Professor of Radiology and Chairman of the Department of Radiology at the University Hospital Münster in Germany told the press. “The low effort required for modifying scan parameters and protocols supports fast and easy experimentation with imaging techniques. These latest features clearly help improve our patient and staff experience and distinguish Philips as one of the main reasons we choose this system.”
MR 7700’s ultra-high gradients and artificial intelligence (AI)-driven touchless patient sensing and motion detection can help address patient volume upswing.
“Enhanced with ultra-high gradients and artificial intelligence, Philips MR 7700 is built to deliver on the high-quality clinical performance expectations of today, and to facilitate the most demanding and promising research programs that will help drive the future of MR imaging, without sacrificing workflow efficiency or wide-bore patient comfort,” said Arjen Radder, General Manager of Magnetic Resonance and Diagnostic X-ray at Philips. “Combined with its AI-driven smart connected imaging capabilities, optimized workflows and integrated clinical solutions help meet the quadruple aim of healthcare by improving MR department productivity, enhancing the patient and staff experience, helping to deliver high-quality diagnostic outcomes.”